首页 > 最新文献

JMIR Research Protocols最新文献

英文 中文
Using Digital Media to Improve Adolescent Resilience and Prevent Mental Health Problems: Protocol for a Scoping Review. 利用数字媒体提高青少年的适应能力并预防心理健康问题:范围界定审查议定书》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-16 DOI: 10.2196/58681
Riris D Rachmayanti, Fatwa Sari Tetra Dewi, Diana Setiyawati, Hario Megatsari, Rian Diana, Retno Vinarti

Background: Global databases show a high prevalence of mental health problems among adolescents (13.5% among those aged 10-14 years and 14.65% for those aged 15-19 years). Successful coping depends on risk and protective factors and how their interaction influences resilience. Higher resilience has been shown to correlate with fewer mental health problems. Digital mental health interventions may help address these problems.

Objective: This protocol serves as a framework for planning a scoping review to map the types of digital communication media and their effectiveness in increasing resilience in youths.

Methods: The Joanna Briggs Institute guidelines will be used: defining the research questions; identifying relevant studies; study selection (we will select articles based on titles and abstracts); charting the data; collating, summarizing, and reporting the results; and consultation. The synthesis will focus on the type of digital media used to increase adolescent resilience skills and the impact they have on adolescent resilience skills. Quantitative and qualitative analyses will be conducted.

Results: The study selection based on keywords was completed in December 2023, the study screening and review were completed in February 2024, and the results manuscript is currently being prepared. This scoping review protocol was funded by the Center for Higher Education Funding and the Indonesia Endowment Fund for Education.

Conclusions: The results of the study will provide a comprehensive overview of commonly used digital media types and their effectiveness in increasing youth resilience. Thus, the results of this scoping review protocol can serve as foundational evidence in deciding further research or interventions. This study may also be used as a guideline for mapping and identifying the type and impact of communication media used to increase adolescents' resilience skills.

International registered report identifier (irrid): DERR1-10.2196/58681.

背景:全球数据库显示,青少年心理健康问题的发病率很高(10-14 岁青少年的发病率为 13.5%,15-19 岁青少年的发病率为 14.65%)。成功应对取决于风险因素和保护因素,以及它们如何相互作用影响复原力。事实证明,较高的复原力与较少的心理健康问题相关。数字心理健康干预措施可能有助于解决这些问题:本方案可作为一个框架,用于规划一项范围研究,以了解数字传播媒体的类型及其在提高青少年抗逆力方面的有效性:将采用乔安娜-布里格斯研究所(Joanna Briggs Institute)的指导方针:确定研究问题;确定相关研究;选择研究(我们将根据标题和摘要选择文章);绘制数据图表;整理、总结和报告结果;以及咨询。综述将重点关注用于提高青少年抗挫折能力的数字媒体类型及其对青少年抗挫折能力的影响。将进行定量和定性分析:根据关键词进行的研究筛选工作已于 2023 年 12 月完成,研究筛选和审查工作已于 2024 年 2 月完成,目前正在准备结果手稿。本范围审查协议由高等教育资助中心和印度尼西亚教育捐赠基金资助:研究结果将全面概述常用的数字媒体类型及其在提高青少年复原力方面的效果。因此,本范围审查规程的结果可作为决定进一步研究或干预措施的基础证据。本研究还可作为一项指南,用于规划和确定用于提高青少年抗挫折能力的传播媒体的类型和影响:DERR1-10.2196/58681。
{"title":"Using Digital Media to Improve Adolescent Resilience and Prevent Mental Health Problems: Protocol for a Scoping Review.","authors":"Riris D Rachmayanti, Fatwa Sari Tetra Dewi, Diana Setiyawati, Hario Megatsari, Rian Diana, Retno Vinarti","doi":"10.2196/58681","DOIUrl":"10.2196/58681","url":null,"abstract":"<p><strong>Background: </strong>Global databases show a high prevalence of mental health problems among adolescents (13.5% among those aged 10-14 years and 14.65% for those aged 15-19 years). Successful coping depends on risk and protective factors and how their interaction influences resilience. Higher resilience has been shown to correlate with fewer mental health problems. Digital mental health interventions may help address these problems.</p><p><strong>Objective: </strong>This protocol serves as a framework for planning a scoping review to map the types of digital communication media and their effectiveness in increasing resilience in youths.</p><p><strong>Methods: </strong>The Joanna Briggs Institute guidelines will be used: defining the research questions; identifying relevant studies; study selection (we will select articles based on titles and abstracts); charting the data; collating, summarizing, and reporting the results; and consultation. The synthesis will focus on the type of digital media used to increase adolescent resilience skills and the impact they have on adolescent resilience skills. Quantitative and qualitative analyses will be conducted.</p><p><strong>Results: </strong>The study selection based on keywords was completed in December 2023, the study screening and review were completed in February 2024, and the results manuscript is currently being prepared. This scoping review protocol was funded by the Center for Higher Education Funding and the Indonesia Endowment Fund for Education.</p><p><strong>Conclusions: </strong>The results of the study will provide a comprehensive overview of commonly used digital media types and their effectiveness in increasing youth resilience. Thus, the results of this scoping review protocol can serve as foundational evidence in deciding further research or interventions. This study may also be used as a guideline for mapping and identifying the type and impact of communication media used to increase adolescents' resilience skills.</p><p><strong>International registered report identifier (irrid): </strong>DERR1-10.2196/58681.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e58681"},"PeriodicalIF":1.4,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methodology for Measuring Intraoperative Blood Loss: Protocol for a Scoping Review. 测量术中失血量的方法:范围审查协议。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-16 DOI: 10.2196/58022
Lätitia Dennin, Jörg Kleeff, Johannes Klose, Ulrich Ronellenfitsch, Artur Rebelo

Background: At present, there is no standardized method for measuring intraoperative blood loss. Rather, the current data on existing methods is very broad and opaque. In many cases, blood loss during surgery is estimated visually by the surgeon. However, it is known that this type of method is very prone to error. Therefore, better standardized methods are needed.

Objective: This study aims to conduct a scoping review to present the currently available methods for measuring intraoperative blood loss. This should help to capture the current status and map and summarize the available evidence for measuring blood loss to identify any gaps.

Methods: We will use a state-of-the-art methodological framework. The databases PubMed (MEDLINE) and Cochrane Library will be searched using a search strategy based on the PICO (Population, Intervention, Comparator, and Outcome) scheme. The search period will be limited to January 01, 2012, to December 31, 2023, and our search will be restricted to clinical trials or clinical studies, randomized controlled trials, and observational studies (in line with PubMed definition of study types). Only publications in English and German will be considered. The intention is to identify clinical studies that define "blood loss" as a target criterion or as a primary or secondary end point. EndNote (version 20.6; Clarivate) will be used for the screening process. The data will be collected and analyzed using Microsoft Excel (version 16.77.1).

Results: The included studies will be listed in a database, and the following basic data will be extracted: title, year of publication, country, language, study type, surgical specialty, and type of procedure. The number of participants will be listed and the distribution of the participants will be documented in terms of gender and age. The following results are extracted: the type of measurement method used to measure blood loss in this study and whether the parameter "blood loss" was recorded as a primary or secondary outcome.

Conclusions: Currently, there is no comparable review, resulting in ambiguous data regarding the prevailing measurement methods for intraoperative blood loss. The aim of this study is to provide a comprehensive overview-from methods of measurement to various formulae for calculating blood loss-and to establish a status quo. This could then serve as a foundation for further studies.

International registered report identifier (irrid): DERR1-10.2196/58022.

背景:目前,还没有测量术中失血量的标准化方法。相反,现有方法的数据非常广泛且不透明。在许多情况下,手术过程中的失血量是由外科医生目测的。但众所周知,这种方法很容易出错。因此,需要更好的标准化方法:本研究旨在进行范围综述,介绍目前可用的术中失血量测量方法。这将有助于了解目前的状况,并绘制和总结测量失血量的现有证据,从而找出差距:我们将采用最先进的方法框架。我们将采用基于 PICO(人口、干预、比较者和结果)方案的检索策略,在 PubMed (MEDLINE) 和 Cochrane Library 数据库中进行检索。检索期限于 2012 年 1 月 1 日至 2023 年 12 月 31 日,检索对象仅限于临床试验或临床研究、随机对照试验和观察性研究(符合 PubMed 对研究类型的定义)。仅考虑英文和德文出版物。目的是找出将 "失血 "定义为目标标准或主要或次要终点的临床研究。筛选过程将使用 EndNote(20.6 版;Clarivate)。将使用 Microsoft Excel(16.77.1 版)收集和分析数据:将在数据库中列出纳入的研究,并提取以下基本数据:标题、发表年份、国家、语言、研究类型、外科专业和手术类型。将列出参与者人数,并记录参与者的性别和年龄分布。提取以下结果:该研究中用于测量失血量的测量方法类型,以及 "失血量 "参数是作为主要结果还是次要结果记录:目前,还没有可比的综述,导致术中失血量的主流测量方法数据不明确。本研究旨在提供一个全面的概览--从测量方法到计算失血量的各种公式--并建立一个现状。国际注册报告标识符(irrid):DERR1-10.2196/58022。
{"title":"Methodology for Measuring Intraoperative Blood Loss: Protocol for a Scoping Review.","authors":"Lätitia Dennin, Jörg Kleeff, Johannes Klose, Ulrich Ronellenfitsch, Artur Rebelo","doi":"10.2196/58022","DOIUrl":"10.2196/58022","url":null,"abstract":"<p><strong>Background: </strong>At present, there is no standardized method for measuring intraoperative blood loss. Rather, the current data on existing methods is very broad and opaque. In many cases, blood loss during surgery is estimated visually by the surgeon. However, it is known that this type of method is very prone to error. Therefore, better standardized methods are needed.</p><p><strong>Objective: </strong>This study aims to conduct a scoping review to present the currently available methods for measuring intraoperative blood loss. This should help to capture the current status and map and summarize the available evidence for measuring blood loss to identify any gaps.</p><p><strong>Methods: </strong>We will use a state-of-the-art methodological framework. The databases PubMed (MEDLINE) and Cochrane Library will be searched using a search strategy based on the PICO (Population, Intervention, Comparator, and Outcome) scheme. The search period will be limited to January 01, 2012, to December 31, 2023, and our search will be restricted to clinical trials or clinical studies, randomized controlled trials, and observational studies (in line with PubMed definition of study types). Only publications in English and German will be considered. The intention is to identify clinical studies that define \"blood loss\" as a target criterion or as a primary or secondary end point. EndNote (version 20.6; Clarivate) will be used for the screening process. The data will be collected and analyzed using Microsoft Excel (version 16.77.1).</p><p><strong>Results: </strong>The included studies will be listed in a database, and the following basic data will be extracted: title, year of publication, country, language, study type, surgical specialty, and type of procedure. The number of participants will be listed and the distribution of the participants will be documented in terms of gender and age. The following results are extracted: the type of measurement method used to measure blood loss in this study and whether the parameter \"blood loss\" was recorded as a primary or secondary outcome.</p><p><strong>Conclusions: </strong>Currently, there is no comparable review, resulting in ambiguous data regarding the prevailing measurement methods for intraoperative blood loss. The aim of this study is to provide a comprehensive overview-from methods of measurement to various formulae for calculating blood loss-and to establish a status quo. This could then serve as a foundation for further studies.</p><p><strong>International registered report identifier (irrid): </strong>DERR1-10.2196/58022.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e58022"},"PeriodicalIF":1.4,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Rutgers Omnibus Study: Protocol for Quarterly Web-Based Surveys to Promote Rapid Tobacco Research. 罗格斯综合研究:促进快速烟草研究的季度网络调查协议。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-16 DOI: 10.2196/58203
Michelle T Bover Manderski, William J Young, Ollie Ganz, Cristine D Delnevo

Background: Rapid and flexible data collection efforts are necessary for effective monitoring and research on tobacco and nicotine product use in a constantly evolving marketplace. The Rutgers Omnibus Survey (1) provides timely data on awareness and use of new and emerging tobacco products among adults in a rapid manner, (2) provides a platform for measurement experiments to help develop and refine measures of tobacco use that reflect the current marketplace, and (3) generates pilot data for grant applications and scientific manuscripts.

Objective: This study aims to document the first 2 years of the Rutgers Omnibus Study through the reporting of methodology, fielding summaries, and sample characteristics.

Methods: Launched in February 2022 and fielded quarterly thereafter, we survey convenience samples of 2000 to 3000 US adults aged 18-45 years recruited from Amazon Mechanical Turk (MTurk) using the MTurk Toolkit by CloudResearch. The questionnaire includes core and rotating modules and is designed to take approximately 10 minutes to complete through Qualtrics. The fielding duration is approximately 10 days per wave. Each wave includes both unique and repeating participants, and responses can be linked across waves by an anonymous ID.

Results: Sample sizes ranged from 2082 (wave 8, December 2023) to 2989 (wave 1, February 2022), and the 8-wave longitudinal dataset included 10,334 participants, of whom 2477 had 3 or more data points. The cost per complete at each wave was low, ranging from US $2.46 to US $3.27 across waves. Key demographics were consistent across waves and similar to that of the general population, while tobacco product trial and past-30-day use were generally higher.

Conclusions: The Rutgers Omnibus Study is a quarterly survey that is effective for rapidly assessing the use of emerging tobacco and nicotine products and can also be leveraged to conduct survey experiments, generate pilot data, and address both cross-sectional and longitudinal research questions.

International registered report identifier (irrid): RR1-10.2196/58203.

背景:在市场不断变化的情况下,要对烟草和尼古丁产品的使用情况进行有效监测和研究,就必须开展快速灵活的数据收集工作。罗格斯综合调查(1)能及时、快速地提供成人对新兴烟草制品的认识和使用情况的数据,(2)为测量实验提供了一个平台,有助于开发和完善反映当前市场的烟草使用测量方法,(3)为拨款申请和科学手稿提供试点数据:本研究旨在通过报告方法、现场总结和样本特征,记录罗格斯综合研究的前两年:该研究于 2022 年 2 月启动,此后每季度进行一次调查。我们使用 CloudResearch 公司的 MTurk 工具包,从亚马逊机械土耳其人(MTurk)中招募了 2000 至 3000 名年龄在 18-45 岁之间的美国成年人,对他们进行了方便抽样调查。问卷包括核心模块和轮换模块,通过 Qualtrics 完成问卷约需 10 分钟。每波调查持续时间约为 10 天。每个波次都包括唯一参与者和重复参与者,各波次的回答可通过匿名 ID 链接:样本量从 2082 个(第 8 波,2023 年 12 月)到 2989 个(第 1 波,2022 年 2 月)不等,8 波纵向数据集包括 10334 名参与者,其中 2477 人有 3 个或更多数据点。每个波次每个完整数据的成本较低,从 2.46 美元到 3.27 美元不等。各次调查的主要人口统计学特征一致,与普通人群相似,而烟草产品试用和过去 30 天的使用率普遍较高:罗格斯综合研究是一项季度调查,可有效快速评估新兴烟草和尼古丁产品的使用情况,还可用于开展调查实验、生成试点数据以及解决横截面和纵向研究问题:RR1-10.2196/58203。
{"title":"The Rutgers Omnibus Study: Protocol for Quarterly Web-Based Surveys to Promote Rapid Tobacco Research.","authors":"Michelle T Bover Manderski, William J Young, Ollie Ganz, Cristine D Delnevo","doi":"10.2196/58203","DOIUrl":"10.2196/58203","url":null,"abstract":"<p><strong>Background: </strong>Rapid and flexible data collection efforts are necessary for effective monitoring and research on tobacco and nicotine product use in a constantly evolving marketplace. The Rutgers Omnibus Survey (1) provides timely data on awareness and use of new and emerging tobacco products among adults in a rapid manner, (2) provides a platform for measurement experiments to help develop and refine measures of tobacco use that reflect the current marketplace, and (3) generates pilot data for grant applications and scientific manuscripts.</p><p><strong>Objective: </strong>This study aims to document the first 2 years of the Rutgers Omnibus Study through the reporting of methodology, fielding summaries, and sample characteristics.</p><p><strong>Methods: </strong>Launched in February 2022 and fielded quarterly thereafter, we survey convenience samples of 2000 to 3000 US adults aged 18-45 years recruited from Amazon Mechanical Turk (MTurk) using the MTurk Toolkit by CloudResearch. The questionnaire includes core and rotating modules and is designed to take approximately 10 minutes to complete through Qualtrics. The fielding duration is approximately 10 days per wave. Each wave includes both unique and repeating participants, and responses can be linked across waves by an anonymous ID.</p><p><strong>Results: </strong>Sample sizes ranged from 2082 (wave 8, December 2023) to 2989 (wave 1, February 2022), and the 8-wave longitudinal dataset included 10,334 participants, of whom 2477 had 3 or more data points. The cost per complete at each wave was low, ranging from US $2.46 to US $3.27 across waves. Key demographics were consistent across waves and similar to that of the general population, while tobacco product trial and past-30-day use were generally higher.</p><p><strong>Conclusions: </strong>The Rutgers Omnibus Study is a quarterly survey that is effective for rapidly assessing the use of emerging tobacco and nicotine products and can also be leveraged to conduct survey experiments, generate pilot data, and address both cross-sectional and longitudinal research questions.</p><p><strong>International registered report identifier (irrid): </strong>RR1-10.2196/58203.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e58203"},"PeriodicalIF":1.4,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Auricular Therapy to Control Pain in Women With Breast Cancer: Protocol for Systematic Review and Meta-Analysis. 控制乳腺癌妇女疼痛的耳穴疗法:系统回顾与元分析协议》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-15 DOI: 10.2196/55792
Ludmila Oliveira Ruela, Caroline de Castro Moura, Bianca Shieu, Yu-Min Cho, Chao Hsing Yeh, Franklin Fernandes Pimentel, Juliana Stefanello

Background: The increased incidence of breast cancer implies the appearance of frequent symptoms associated with disease and treatments, such as pain. For the management of this issue, auricular therapy has been used in a complementary manner, especially for its safety and analgesic action.

Objective: This systematic review aims to summarize available evidence on the effects of auricular therapy on pain in women undergoing breast cancer treatment.

Methods: This is a systematic review that includes randomized controlled trials that evaluated the effects of auricular therapy on pain in women with breast cancer, as compared with other interventions (sham or placebo auricular therapy, other nonpharmacological interventions, and routine pain treatments) during the treatment of the disease. Pain, whether induced or not by cancer treatments, is the main outcome to be evaluated. The search for the studies was performed in the following databases: MEDLINE through PubMed, CINAHL, CENTRAL, Embase, Web of Science, Scopus, VHL, TCIM Americas Network, CNKI, and Wanfang Data. The reviewers have independently evaluated the full texts, and in the near future, they will extract the data and assess the risk of bias in the included studies. The certainty of the evidence will be assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE), and a meta-analysis will be carried out to evaluate the intervention, considering the homogeneity of the results, using the Cochran Q test and quantified by the Higgins inconsistency index. The guidelines of the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) have been respected in the elaboration of this protocol.

Results: The records screening stage has been completed, and the synthesis and meta-analysis were conducted in February 2024. We hope to have finished the preparation of the paper for publication by September 2024. Review reporting will follow standard guidelines for reporting systematic reviews. The results will be published in peer-reviewed scientific journals.

Conclusions: This review will compile the strength of evidence for the use of auricular therapy in the management of pain in women with breast cancer during the treatment of the disease, identifying gaps in the available evidence as well as assisting health professionals in indicating the intervention for clinical practice.

Trial registration: PROSPERO CRD42022382433; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382433.

International registered report identifier (irrid): DERR1-10.2196/55792.

背景:乳腺癌发病率的增加意味着出现与疾病和治疗相关的常见症状,如疼痛。为了解决这一问题,耳穴疗法已被用于辅助治疗,特别是由于其安全性和镇痛作用:本系统综述旨在总结耳穴疗法对接受乳腺癌治疗的妇女疼痛的影响的现有证据:这是一项系统性综述,其中包括评估耳穴疗法对乳腺癌女性患者疼痛影响的随机对照试验,并与疾病治疗期间的其他干预措施(假性或安慰剂耳穴疗法、其他非药物干预措施和常规疼痛治疗)进行了比较。疼痛(无论是否由癌症治疗引起)是需要评估的主要结果。有关研究的检索在以下数据库中进行:MEDLINE through PubMed、CINAHL、CENTRAL、Embase、Web of Science、Scopus、VHL、TCIM Americas Network、CNKI 和万方数据。审稿人已独立评估了全文,并将在近期提取数据,评估纳入研究的偏倚风险。证据的确定性将采用建议、评估、发展和评价分级法(GRADE)进行评估,考虑到结果的同质性,将采用 Cochran Q 检验和 Higgins 不一致性指数进行量化,对干预措施进行荟萃分析评估。在制定本方案时,遵守了 PRISMA-P(系统综述和元分析方案的首选报告项目)的指导方针:记录筛选阶段已经完成,2024 年 2 月进行了综合和荟萃分析。我们希望在 2024 年 9 月之前完成论文发表的准备工作。综述报告将遵循系统综述报告的标准指南。研究结果将在同行评审的科学期刊上发表:本综述将对使用耳穴疗法治疗乳腺癌女性患者在疾病治疗期间的疼痛的证据强度进行梳理,找出现有证据中的不足之处,并协助医疗专业人员为临床实践指明干预措施:PROSPERO CRD42022382433;https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382433.International 注册报告标识符 (irrid):DERR1-10.2196/55792。
{"title":"Auricular Therapy to Control Pain in Women With Breast Cancer: Protocol for Systematic Review and Meta-Analysis.","authors":"Ludmila Oliveira Ruela, Caroline de Castro Moura, Bianca Shieu, Yu-Min Cho, Chao Hsing Yeh, Franklin Fernandes Pimentel, Juliana Stefanello","doi":"10.2196/55792","DOIUrl":"10.2196/55792","url":null,"abstract":"<p><strong>Background: </strong>The increased incidence of breast cancer implies the appearance of frequent symptoms associated with disease and treatments, such as pain. For the management of this issue, auricular therapy has been used in a complementary manner, especially for its safety and analgesic action.</p><p><strong>Objective: </strong>This systematic review aims to summarize available evidence on the effects of auricular therapy on pain in women undergoing breast cancer treatment.</p><p><strong>Methods: </strong>This is a systematic review that includes randomized controlled trials that evaluated the effects of auricular therapy on pain in women with breast cancer, as compared with other interventions (sham or placebo auricular therapy, other nonpharmacological interventions, and routine pain treatments) during the treatment of the disease. Pain, whether induced or not by cancer treatments, is the main outcome to be evaluated. The search for the studies was performed in the following databases: MEDLINE through PubMed, CINAHL, CENTRAL, Embase, Web of Science, Scopus, VHL, TCIM Americas Network, CNKI, and Wanfang Data. The reviewers have independently evaluated the full texts, and in the near future, they will extract the data and assess the risk of bias in the included studies. The certainty of the evidence will be assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE), and a meta-analysis will be carried out to evaluate the intervention, considering the homogeneity of the results, using the Cochran Q test and quantified by the Higgins inconsistency index. The guidelines of the PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) have been respected in the elaboration of this protocol.</p><p><strong>Results: </strong>The records screening stage has been completed, and the synthesis and meta-analysis were conducted in February 2024. We hope to have finished the preparation of the paper for publication by September 2024. Review reporting will follow standard guidelines for reporting systematic reviews. The results will be published in peer-reviewed scientific journals.</p><p><strong>Conclusions: </strong>This review will compile the strength of evidence for the use of auricular therapy in the management of pain in women with breast cancer during the treatment of the disease, identifying gaps in the available evidence as well as assisting health professionals in indicating the intervention for clinical practice.</p><p><strong>Trial registration: </strong>PROSPERO CRD42022382433; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=382433.</p><p><strong>International registered report identifier (irrid): </strong>DERR1-10.2196/55792.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e55792"},"PeriodicalIF":1.4,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11522657/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervention for the Management of Neuropsychiatric Symptoms to Reduce Caregiver Stress: Protocol for the Mindful and Self-Compassion Care Intervention for Caregivers of Persons Living With Dementia. 管理神经精神症状以减轻护理者压力的干预措施:针对痴呆症患者护理人员的心灵和自我同情护理干预方案》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-11 DOI: 10.2196/58356
Aniyah Travis, Arden O'Donnell, Natalia Giraldo-Santiago, Sarah M Stone, Daniel Torres, Shelley R Adler, Ana-Maria Vranceanu, Christine S Ritchie
<p><strong>Background: </strong>Stress related to Alzheimer disease and related dementias (ADRD) is common, particularly among those who care for persons with challenging behaviors and personality or mood changes. Mindfulness and self-compassion programs are efficacious for managing stress. The skills of mindfulness and self-compassion, however, must be integrated with behavioral management skills in order to effectively improve caregiver stress.</p><p><strong>Objective: </strong>In this study, we aimed to describe the development of the Mindful and Self-Compassionate Care (MASC) program, the first program that combines mindfulness and self-compassion with behavioral management skills to decrease caregiver stress, and its evaluation in the Supporting Our Caregivers in ADRD Learning (SOCIAL) study.</p><p><strong>Methods: </strong>Using the National Institutes of Health (NIH) stage model, we describe 3 phases of work encompassing NIH Stages 1A and 1B. In phase 1, we conducted 5 focus groups (N=28) of stressed individuals caring for persons with ADRD and challenging behaviors. Rapid data analysis informed the development of a 6-week online intervention. Phase 2 (NIH stage 1A) includes an open pilot (N>10) with optional exit interviews. Phase 3 (NIH stage 1B) is a feasibility randomized controlled trial of the intervention versus the Health Education Program control. Primary outcomes focus on feasibility with secondary outcomes encompassing acceptability, credibility, fidelity, and signals of preliminary efficacy. Phase 1 follows traditional recommendations for qualitative analyses (at the point of thematic saturation) which was achieved after 5 focus groups (N=28). For the phase 2 open pilot, up to 12 participants will be recruited. For the phase 3 feasibility study, recruitment of 80 caregivers will allow the assessment of feasibility benchmarks. Data for phase 1 included 5 focus groups. In phases 2 and 3, data collection will occur through REDCap (Research Electronic Data Capture; Vanderbilt University) surveys and an optional qualitative exit interview. Analyses will include hybrid inductive-deductive analyses for qualitative data and assessment of changes in our intervention targets and outcomes using t tests and correlation analyses.</p><p><strong>Results: </strong>In phase 1, caregivers reported interest in a brief, online stress management program. Participants held misconceptions about mindfulness and self-compassion, but after detailed explanation thoughts, these skills could be helpful when directly linked to implementation during caregiving routines. Phases 2 and 3 will be completed by the end of 2025.</p><p><strong>Conclusions: </strong>We describe the protocol for the Supporting Our Caregivers in ADRD Learning study, as well as the development and feasibility testing of the Mindful and Self-Compassionate Care intervention. Future work will include a fully powered efficacy-effectiveness randomized controlled trial.</p><p><strong>Trial re
背景:与阿尔茨海默病和相关痴呆症(ADRD)有关的压力很常见,尤其是在那些照顾有挑战行为、性格或情绪变化的患者的人当中。正念和自我同情计划可有效控制压力。然而,正念和自我同情技能必须与行为管理技能相结合,才能有效改善护理人员的压力:在本研究中,我们旨在描述 "正念与自我同情护理(MASC)"项目的发展情况,该项目是首个将正念和自我同情与行为管理技能相结合以减轻护理者压力的项目,并在 "支持我们的护理者学习 ADRD(SOCIAL)"研究中对其进行了评估:采用美国国立卫生研究院(NIH)的阶段模型,我们描述了包含 NIH 阶段 1A 和 1B 的 3 个工作阶段。在第 1 阶段,我们进行了 5 次焦点小组讨论(N=28),讨论对象是照顾患有 ADRD 并有挑战性行为的患者的压力较大的个人。通过快速数据分析,我们制定了为期 6 周的在线干预措施。第 2 阶段(NIH 阶段 1A)包括公开试点(N>10)和可选的退出访谈。第 3 阶段(NIH 阶段 1B)是干预与健康教育计划对照的可行性随机对照试验。主要结果侧重于可行性,次要结果包括可接受性、可信度、忠实性和初步疗效信号。第 1 阶段遵循传统的定性分析建议(主题饱和点),在 5 个焦点小组(N=28)之后达到饱和。第 2 阶段的公开试点将招募多达 12 名参与者。第 3 阶段的可行性研究将招募 80 名护理人员,以评估可行性基准。第 1 阶段的数据包括 5 个焦点小组。在第 2 和第 3 阶段,将通过 REDCap(研究电子数据采集;范德堡大学)调查和可选的定性离职访谈收集数据。分析将包括对定性数据进行归纳-演绎混合分析,以及使用 t 检验和相关性分析评估干预目标和结果的变化:在第一阶段,护理人员表示对简短的在线压力管理项目感兴趣。参与者对正念和自我同情存在误解,但经过详细的思想解释后,他们认为这些技能与日常护理工作中的实施直接相关,可能会有所帮助。第 2 和第 3 阶段将于 2025 年底完成:我们介绍了 "支持我们的护理者学习 ADRD "研究的方案,以及 "正念和自我同情护理 "干预的开发和可行性测试。未来的工作将包括一项完全有效的疗效随机对照试验:临床试验 NCT05847153; https://clinicaltrials.gov/study/NCT05847153; 和 ClinicalTrials.gov NCT06276023; https://clinicaltrials.gov/study/NCT06276023.International 注册报告标识符 (irrid):DERR1-10.2196/58356。
{"title":"Intervention for the Management of Neuropsychiatric Symptoms to Reduce Caregiver Stress: Protocol for the Mindful and Self-Compassion Care Intervention for Caregivers of Persons Living With Dementia.","authors":"Aniyah Travis, Arden O'Donnell, Natalia Giraldo-Santiago, Sarah M Stone, Daniel Torres, Shelley R Adler, Ana-Maria Vranceanu, Christine S Ritchie","doi":"10.2196/58356","DOIUrl":"10.2196/58356","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Stress related to Alzheimer disease and related dementias (ADRD) is common, particularly among those who care for persons with challenging behaviors and personality or mood changes. Mindfulness and self-compassion programs are efficacious for managing stress. The skills of mindfulness and self-compassion, however, must be integrated with behavioral management skills in order to effectively improve caregiver stress.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;In this study, we aimed to describe the development of the Mindful and Self-Compassionate Care (MASC) program, the first program that combines mindfulness and self-compassion with behavioral management skills to decrease caregiver stress, and its evaluation in the Supporting Our Caregivers in ADRD Learning (SOCIAL) study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Using the National Institutes of Health (NIH) stage model, we describe 3 phases of work encompassing NIH Stages 1A and 1B. In phase 1, we conducted 5 focus groups (N=28) of stressed individuals caring for persons with ADRD and challenging behaviors. Rapid data analysis informed the development of a 6-week online intervention. Phase 2 (NIH stage 1A) includes an open pilot (N&gt;10) with optional exit interviews. Phase 3 (NIH stage 1B) is a feasibility randomized controlled trial of the intervention versus the Health Education Program control. Primary outcomes focus on feasibility with secondary outcomes encompassing acceptability, credibility, fidelity, and signals of preliminary efficacy. Phase 1 follows traditional recommendations for qualitative analyses (at the point of thematic saturation) which was achieved after 5 focus groups (N=28). For the phase 2 open pilot, up to 12 participants will be recruited. For the phase 3 feasibility study, recruitment of 80 caregivers will allow the assessment of feasibility benchmarks. Data for phase 1 included 5 focus groups. In phases 2 and 3, data collection will occur through REDCap (Research Electronic Data Capture; Vanderbilt University) surveys and an optional qualitative exit interview. Analyses will include hybrid inductive-deductive analyses for qualitative data and assessment of changes in our intervention targets and outcomes using t tests and correlation analyses.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In phase 1, caregivers reported interest in a brief, online stress management program. Participants held misconceptions about mindfulness and self-compassion, but after detailed explanation thoughts, these skills could be helpful when directly linked to implementation during caregiving routines. Phases 2 and 3 will be completed by the end of 2025.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;We describe the protocol for the Supporting Our Caregivers in ADRD Learning study, as well as the development and feasibility testing of the Mindful and Self-Compassionate Care intervention. Future work will include a fully powered efficacy-effectiveness randomized controlled trial.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Trial re","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e58356"},"PeriodicalIF":1.4,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comparison of Conventional Root Canal Sealers With Ones That Use Green Synthesized Nanoparticles for Antimicrobial Activity: Protocol for a Systematic Review. 传统根管封闭剂与使用绿色合成纳米粒子的根管封闭剂在抗菌活性方面的比较:系统综述协议。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-11 DOI: 10.2196/51351
Abubaker Mohamed, Enas Ismail, Razia Z Adam

Background: Root canal failure and secondary endodontic infection are frequent clinical scenarios in dentistry. The main microorganisms implicated in root canal therapy failure are persistent Enterococcus faecalis, Candida albicans, and Staphylococcus aureus. To combat the impact of disease resistance, scientists are concentrating on alternative antimicrobial root canal sealers. Nanomaterials are a recent development in endodontic materials that exhibit great antimicrobial properties, making them an ideal material choice for root canal sealers.

Objective: This systematic review aims to compare the antimicrobial properties of conventional root canal sealers to those incorporating green synthesized nanoparticles between 2010 and 2024.

Methods: A well-constructed protocol was established and registered with PROSPERO (CRD42021286373). Ethics approval was obtained from the Biomedical Research and Ethics Committee from the University of the Western Cape (UWC; BM22/1/4). PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) reporting guidelines were followed. The included criteria demonstrate the green synthesized nanoparticles studies where the nanoparticles (NPs) are incorporated in root canal sealers. MeSH (Medical Subject Headings) terms were used for the search strategy of the systematic electronic databases for articles published in English between 2010 and 2024. The selected databases included Scopus, PubMed, Web of Science, Science Direct, EBSCOhost, SpringerLink, and Wiley Online. A quality assessment tool for laboratory studies will be used to critically appraise the included studies. If applicable, statistical measures (mean, SD, etc) will be used for data analysis and presentation of the results.

Results: The protocol is registered with PROSPERO. A preliminary search was conducted using a determined search strategy across 8 electronic databases, and the review is now complete.

Conclusions: It is anticipated that the results of this systematic review may reveal the increased interest and application for nanoparticle-enhanced root canal sealers. This will aid in the future development of root canal sealants and mitigate the risk of endodontic failure.

Trial registration: PROSPERO CRD42021286373; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=286373.

International registered report identifier (irrid): DERR1-10.2196/51351.

背景:根管治疗失败和继发性根管感染是牙科临床上经常出现的情况。导致根管治疗失败的主要微生物是顽固性粪肠球菌、白色念珠菌和金黄色葡萄球菌。为了消除抗药性的影响,科学家们正在集中研究替代性抗菌根管封闭剂。纳米材料是最近发展起来的一种根管治疗材料,具有很好的抗菌性能,是根管封闭剂的理想材料选择:本系统综述旨在比较 2010 年至 2024 年间传统根管封闭剂与含有绿色合成纳米粒子的根管封闭剂的抗菌性能:方法:制定并在 PROSPERO(CRD42021286373)注册了一个结构合理的方案。西开普大学(UWC;BM22/1/4)的生物医学研究与伦理委员会批准了该项目。研究遵循了 PRISMA-P(系统综述和元分析协议的首选报告项目)报告指南。纳入的标准表明,绿色合成纳米粒子研究中的纳米粒子(NPs)被纳入根管封闭剂中。在系统性电子数据库中使用 MeSH(医学主题词表)术语搜索 2010 年至 2024 年间发表的英文文章。所选数据库包括 Scopus、PubMed、Web of Science、Science Direct、EBSCOhost、SpringerLink 和 Wiley Online。将使用实验室研究质量评估工具对纳入的研究进行严格评估。如果适用,将使用统计量(平均值、SD 等)进行数据分析和结果展示:研究方案已在 PROSPERO 注册。采用确定的检索策略在 8 个电子数据库中进行了初步检索,审查工作现已完成:预计本系统综述的结果将揭示纳米粒子增强型根管封闭剂的兴趣和应用的增加。这将有助于根管封闭剂的未来发展,并降低根管治疗失败的风险:PROSPERO CRD42021286373; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=286373.International 注册报告标识符 (irrid):DERR1-10.2196/51351。
{"title":"A Comparison of Conventional Root Canal Sealers With Ones That Use Green Synthesized Nanoparticles for Antimicrobial Activity: Protocol for a Systematic Review.","authors":"Abubaker Mohamed, Enas Ismail, Razia Z Adam","doi":"10.2196/51351","DOIUrl":"10.2196/51351","url":null,"abstract":"<p><strong>Background: </strong>Root canal failure and secondary endodontic infection are frequent clinical scenarios in dentistry. The main microorganisms implicated in root canal therapy failure are persistent Enterococcus faecalis, Candida albicans, and Staphylococcus aureus. To combat the impact of disease resistance, scientists are concentrating on alternative antimicrobial root canal sealers. Nanomaterials are a recent development in endodontic materials that exhibit great antimicrobial properties, making them an ideal material choice for root canal sealers.</p><p><strong>Objective: </strong>This systematic review aims to compare the antimicrobial properties of conventional root canal sealers to those incorporating green synthesized nanoparticles between 2010 and 2024.</p><p><strong>Methods: </strong>A well-constructed protocol was established and registered with PROSPERO (CRD42021286373). Ethics approval was obtained from the Biomedical Research and Ethics Committee from the University of the Western Cape (UWC; BM22/1/4). PRISMA-P (Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols) reporting guidelines were followed. The included criteria demonstrate the green synthesized nanoparticles studies where the nanoparticles (NPs) are incorporated in root canal sealers. MeSH (Medical Subject Headings) terms were used for the search strategy of the systematic electronic databases for articles published in English between 2010 and 2024. The selected databases included Scopus, PubMed, Web of Science, Science Direct, EBSCOhost, SpringerLink, and Wiley Online. A quality assessment tool for laboratory studies will be used to critically appraise the included studies. If applicable, statistical measures (mean, SD, etc) will be used for data analysis and presentation of the results.</p><p><strong>Results: </strong>The protocol is registered with PROSPERO. A preliminary search was conducted using a determined search strategy across 8 electronic databases, and the review is now complete.</p><p><strong>Conclusions: </strong>It is anticipated that the results of this systematic review may reveal the increased interest and application for nanoparticle-enhanced root canal sealers. This will aid in the future development of root canal sealants and mitigate the risk of endodontic failure.</p><p><strong>Trial registration: </strong>PROSPERO CRD42021286373; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=286373.</p><p><strong>International registered report identifier (irrid): </strong>DERR1-10.2196/51351.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e51351"},"PeriodicalIF":1.4,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of a Person-Centered Interdisciplinary Rehabilitation Treatment of Post-COVID-19 Condition: Protocol for a Single-Case Experimental Design Study. 以人为本的跨学科康复治疗对后 COVID-19 症状的疗效:单病例实验设计研究方案。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-11 DOI: 10.2196/63951
Carolina M H Wiertz, Thijs van Meulenbroek, Cynthia Lamper, Bea Hemmen, Simone Sep, Ivan Huijnen, Marielle E J B Goossens, Jako Burgers, Jeanine Verbunt
<p><strong>Background: </strong>Patients with post-COVID-19 condition (PCC) experience a wide range of complaints (physical, cognitive, and mental), sometimes with high levels of disability in daily activities. Evidence of effective interdisciplinary rehabilitation treatment is lacking. A person-centered, biopsychosocial, interdisciplinary rehabilitation program, adapted to expert opinions and the patient's needs, was therefore developed.</p><p><strong>Objective: </strong>This study aims to present a study protocol for a clinical trial to evaluate the effect of a new, person-centered, interdisciplinary rehabilitation treatment for PCC. It is aimed at improving participation in society and health-related quality of life in patients with PCC who perceive a high level of disability in daily activities or participation.</p><p><strong>Methods: </strong>A total of 20 Dutch adults, aged 18 years or older, with high levels of disability in daily activities and participation in society will be included in this replicated and randomized single-case experimental design study, from October 2023 onward. The replicated and randomized single-case experimental design consists of 3 phases. The baseline phase is the observational period, in which no specific treatment will be given. In the intervention phase, patients will receive the new outpatient treatment 3 times a week for 12 weeks, followed by a 12-week follow-up phase. During the intervention phase, the treatment will be personalized according to the patient's physical, mental, and cognitive symptoms and goals. The treatment team can consist of a rehabilitation physician, physiotherapist, occupational therapist, speech therapist, and psychologist. The primary outcomes of the study are daily diaries, which consist of 8 questions selected from validated questionnaires (Utrecht Scale for Evaluation of Rehabilitation-Participation, EQ-5D-5L, and the Hospital Anxiety and Depression Scale). The other primary outcome measurements are participation in society (Utrecht Scale for Evaluation of Rehabilitation-Participation) and health-related quality of life (EQ-5D-5L). The secondary outcomes are physical tests and validated questionnaires aimed at physical, mental, and cognitive complaints. Effect evaluation based on daily assessments will include visual analysis, calculation of effect sizes (Nonoverlap of All Pairs), randomization tests, and multilevel analysis. In addition, other analyses will be based on ANOVA or a 2-tailed Student t test.</p><p><strong>Results: </strong>Data collection for this study started in October 2023 and is planned to be completed in July 2024. The results will be published in peer-reviewed journals and presented at international conferences.</p><p><strong>Conclusions: </strong>This is the first study investigating the effect of an interdisciplinary rehabilitation treatment with a person-centered, biopsychosocial approach in patients with PCC. Our findings will help to improve the treatmen
背景:COVID-19 后遗症(PCC)患者会出现各种不适(身体、认知和精神方面),有时在日常活动中会出现高度残疾。目前缺乏有效的跨学科康复治疗证据。因此,我们根据专家的意见和患者的需求,制定了一项以人为本的生物心理社会跨学科康复计划:本研究旨在介绍一项临床试验的研究方案,以评估以人为本、跨学科的新型 PCC 康复治疗的效果。目的:本研究旨在介绍一项临床试验的研究方案,以评估一种以人为本、跨学科的新型 PCC 康复治疗方法的效果,其目的是改善 PCC 患者的社会参与和与健康相关的生活质量,因为这些患者认为自己在日常活动或参与方面存在严重残疾:从 2023 年 10 月起,共有 20 名年龄在 18 岁或以上、在日常活动和社会参与方面有高度残疾的荷兰成年人将被纳入这项复制和随机单病例实验设计研究。复制和随机单一病例实验设计包括三个阶段。基线阶段为观察期,在此期间不进行任何具体治疗。在干预阶段,患者将接受新的门诊治疗,每周 3 次,为期 12 周,然后是为期 12 周的随访阶段。在干预阶段,将根据患者的身体、精神和认知症状及目标进行个性化治疗。治疗团队可由康复医师、物理治疗师、职业治疗师、语言治疗师和心理学家组成。研究的主要结果是每日日记,其中包括从有效问卷(乌得勒支康复参与评估量表、EQ-5D-5L 和医院焦虑抑郁量表)中选出的 8 个问题。其他主要测量结果包括社会参与度(乌得勒支康复参与度评估量表)和与健康相关的生活质量(EQ-5D-5L)。次要结果是身体测试和针对身体、精神和认知症状的有效问卷。基于日常评估的效果评估将包括视觉分析、效果大小计算(所有配对的非重叠)、随机化测试和多层次分析。此外,其他分析将基于方差分析或双尾学生 t 检验:本研究的数据收集工作于 2023 年 10 月开始,计划于 2024 年 7 月完成。研究结果将在同行评审期刊上发表,并在国际会议上展示:这是第一项调查跨学科康复治疗效果的研究,该治疗采用以人为本的生物心理社会方法,适用于 PCC 患者。我们的研究结果将有助于改善对 PCC 患者的治疗和支持:德国临床试验注册中心 DRKS00032636;https://drks.de/search/en/trial/DRKS00032636.International 注册报告标识符 (irrid):DERR1-10.2196/63951。
{"title":"Effectiveness of a Person-Centered Interdisciplinary Rehabilitation Treatment of Post-COVID-19 Condition: Protocol for a Single-Case Experimental Design Study.","authors":"Carolina M H Wiertz, Thijs van Meulenbroek, Cynthia Lamper, Bea Hemmen, Simone Sep, Ivan Huijnen, Marielle E J B Goossens, Jako Burgers, Jeanine Verbunt","doi":"10.2196/63951","DOIUrl":"10.2196/63951","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Patients with post-COVID-19 condition (PCC) experience a wide range of complaints (physical, cognitive, and mental), sometimes with high levels of disability in daily activities. Evidence of effective interdisciplinary rehabilitation treatment is lacking. A person-centered, biopsychosocial, interdisciplinary rehabilitation program, adapted to expert opinions and the patient's needs, was therefore developed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aims to present a study protocol for a clinical trial to evaluate the effect of a new, person-centered, interdisciplinary rehabilitation treatment for PCC. It is aimed at improving participation in society and health-related quality of life in patients with PCC who perceive a high level of disability in daily activities or participation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 20 Dutch adults, aged 18 years or older, with high levels of disability in daily activities and participation in society will be included in this replicated and randomized single-case experimental design study, from October 2023 onward. The replicated and randomized single-case experimental design consists of 3 phases. The baseline phase is the observational period, in which no specific treatment will be given. In the intervention phase, patients will receive the new outpatient treatment 3 times a week for 12 weeks, followed by a 12-week follow-up phase. During the intervention phase, the treatment will be personalized according to the patient's physical, mental, and cognitive symptoms and goals. The treatment team can consist of a rehabilitation physician, physiotherapist, occupational therapist, speech therapist, and psychologist. The primary outcomes of the study are daily diaries, which consist of 8 questions selected from validated questionnaires (Utrecht Scale for Evaluation of Rehabilitation-Participation, EQ-5D-5L, and the Hospital Anxiety and Depression Scale). The other primary outcome measurements are participation in society (Utrecht Scale for Evaluation of Rehabilitation-Participation) and health-related quality of life (EQ-5D-5L). The secondary outcomes are physical tests and validated questionnaires aimed at physical, mental, and cognitive complaints. Effect evaluation based on daily assessments will include visual analysis, calculation of effect sizes (Nonoverlap of All Pairs), randomization tests, and multilevel analysis. In addition, other analyses will be based on ANOVA or a 2-tailed Student t test.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Data collection for this study started in October 2023 and is planned to be completed in July 2024. The results will be published in peer-reviewed journals and presented at international conferences.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This is the first study investigating the effect of an interdisciplinary rehabilitation treatment with a person-centered, biopsychosocial approach in patients with PCC. Our findings will help to improve the treatmen","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e63951"},"PeriodicalIF":1.4,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning Styles of Medical Students, Surgical Residents, Medical Staff, and General Surgery Teachers When Learning Surgery: Protocol for a Scoping Review. 医学生、外科住院医师、医务人员和普通外科教师在学习外科手术时的学习风格:范围审查协议》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-11 DOI: 10.2196/57229
Gabriela Gouvea Silva, Carlos Dario da Silva Costa, Bruno Cardoso Gonçalves, Luiz Vianney Cidrão Nunes, Emerson Roberto Dos Santos, Sonia Maria Maciel Lopes, Alba Regina de Abreu Lima, Vânia Maria Sabadoto Brienze, Thaís Santana Gastardelo Bizotto, Júlio César André

Background: Learning styles are biological and developmental configurations of personal characteristics that make the same teaching method effective for some and ineffective for others. Studies support a relationship between learning style and career choices in medicine, resulting in learning style patterns being observed in different residency programs, including in general surgery, from medical school to the last stages of training. The methodologies, populations, and contexts of the few studies pertinent to the matter are very different from one another, and a scoping review on this theme will enhance and organize what is already known.

Objective: The goal of this study is to identify and map out data from studies on the learning styles of medical students, surgical residents, medical staff, and surgical teachers.

Methods: The review will consider studies on the learning styles of medical students in a clinical cycle or internship, surgical residents with no restriction on year of residency, medical staff in general surgery, or general surgery's medical faculty. Primary studies published in English, with no specific time frame, will be considered. The search will be carried out in four databases, and reference lists will be searched for additional studies. Duplicates will be removed, and two independent reviewers will screen the titles, abstracts, and full texts of the selected studies. Data collection will be performed using a tool developed by the researchers. A results summary will be presented with figures, narratives, and tables. A quantitative and qualitative analysis will be carried out and further results will be shared.

Results: The search was funded on September 25, 2023. Data collection was performed in the two following months. Of the 213 articles found, 135 were excluded due to duplication. The remaining 78 articles will have their titles and abstracts analyzed by three of the researchers independently to select those that meet the eligibility criteria. This data is expected to be published in the first semester of 2025.

Conclusions: Conducting a scoping review is the best way to map what is known about a subject. Understanding how students, residents, staff, and even teachers prefer to learn surgery is key to staying up to date and knowing how to best educate those pursuing a surgical career.

Trial registration: Open Science Framework 75ku4; https://osf.io/75ku4.

International registered report identifier (irrid): DERR1-10.2196/57229.

背景:学习风格是个人特征的生物和发展组合,同样的教学方法对某些人有效,对另一些人则无效。研究支持学习风格与医学职业选择之间的关系,因此在不同的住院医师培训项目中,包括普外科,从医学院到培训的最后阶段,都能观察到学习风格模式。与此问题相关的几项研究在方法、人群和背景方面都大相径庭,对这一主题进行范围综述将有助于加强和整理已有的知识:本研究的目标是确定和梳理有关医学生、外科住院医师、医务人员和外科教师学习风格的研究数据:综述将考虑有关临床周期或实习期医学生、外科住院医师(不限住院年限)、普外科医务人员或普外科医学教师学习风格的研究。将考虑以英语发表的、没有特定时间框架的主要研究。将在四个数据库中进行搜索,并在参考文献列表中搜索其他研究。重复的研究将被删除,两名独立审稿人将对所选研究的标题、摘要和全文进行筛选。数据收集将使用研究人员开发的工具进行。研究结果摘要将以图、叙述和表格的形式呈现。将进行定量和定性分析,并分享进一步的结果:搜索经费于 2023 年 9 月 25 日到位。数据收集工作在随后的两个月内进行。在找到的 213 篇文章中,135 篇因重复而被排除。其余 78 篇文章的标题和摘要将由三位研究人员独立分析,选出符合资格标准的文章。这些数据预计将于 2025 年上半年公布:进行范围综述是了解某一主题已知情况的最佳方法。了解学生、住院医师、教职员工甚至教师喜欢如何学习外科手术是跟上时代步伐的关键,也是了解如何最好地教育那些追求外科事业的人的关键:开放科学框架 75ku4;https://osf.io/75ku4.International 注册报告标识符 (irrid):DERR1-10.2196/57229。
{"title":"Learning Styles of Medical Students, Surgical Residents, Medical Staff, and General Surgery Teachers When Learning Surgery: Protocol for a Scoping Review.","authors":"Gabriela Gouvea Silva, Carlos Dario da Silva Costa, Bruno Cardoso Gonçalves, Luiz Vianney Cidrão Nunes, Emerson Roberto Dos Santos, Sonia Maria Maciel Lopes, Alba Regina de Abreu Lima, Vânia Maria Sabadoto Brienze, Thaís Santana Gastardelo Bizotto, Júlio César André","doi":"10.2196/57229","DOIUrl":"10.2196/57229","url":null,"abstract":"<p><strong>Background: </strong>Learning styles are biological and developmental configurations of personal characteristics that make the same teaching method effective for some and ineffective for others. Studies support a relationship between learning style and career choices in medicine, resulting in learning style patterns being observed in different residency programs, including in general surgery, from medical school to the last stages of training. The methodologies, populations, and contexts of the few studies pertinent to the matter are very different from one another, and a scoping review on this theme will enhance and organize what is already known.</p><p><strong>Objective: </strong>The goal of this study is to identify and map out data from studies on the learning styles of medical students, surgical residents, medical staff, and surgical teachers.</p><p><strong>Methods: </strong>The review will consider studies on the learning styles of medical students in a clinical cycle or internship, surgical residents with no restriction on year of residency, medical staff in general surgery, or general surgery's medical faculty. Primary studies published in English, with no specific time frame, will be considered. The search will be carried out in four databases, and reference lists will be searched for additional studies. Duplicates will be removed, and two independent reviewers will screen the titles, abstracts, and full texts of the selected studies. Data collection will be performed using a tool developed by the researchers. A results summary will be presented with figures, narratives, and tables. A quantitative and qualitative analysis will be carried out and further results will be shared.</p><p><strong>Results: </strong>The search was funded on September 25, 2023. Data collection was performed in the two following months. Of the 213 articles found, 135 were excluded due to duplication. The remaining 78 articles will have their titles and abstracts analyzed by three of the researchers independently to select those that meet the eligibility criteria. This data is expected to be published in the first semester of 2025.</p><p><strong>Conclusions: </strong>Conducting a scoping review is the best way to map what is known about a subject. Understanding how students, residents, staff, and even teachers prefer to learn surgery is key to staying up to date and knowing how to best educate those pursuing a surgical career.</p><p><strong>Trial registration: </strong>Open Science Framework 75ku4; https://osf.io/75ku4.</p><p><strong>International registered report identifier (irrid): </strong>DERR1-10.2196/57229.</p>","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e57229"},"PeriodicalIF":1.4,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142406401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT Study): Protocol for a Randomized Controlled Trial. 改善非裔美国人肾移植移植结果差异的多方面干预(MITIGAAT 研究):随机对照试验协议》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-10 DOI: 10.2196/57784
Morgan Overstreet, Hannah Culpepper, Deanna DeHoff, Mulugeta Gebregziabher, Maria Aurora Posadas Salas, Zemin Su, Jessica Chandler, Felicia Bartlett, Paige Dunton, Taylor Carcella, David Taber
<p><strong>Background: </strong>The outcome disparities for African American recipients of kidney transplant is a public health issue that has plagued the field of transplant since its inception. Based on national data, African American recipients have nearly twice the risk of graft loss at 5 years after transplant, when compared with White recipients. Evidence demonstrates that medication nonadherence and high tacrolimus variability substantially impact graft outcomes and racial disparities, most notably late (>2 years) after the transplant. Nonadherence is a leading cause of graft loss. Prospective multicenter data demonstrate that one-third of all graft loss are directly attributed to nonadherence. We have spent 10 years of focused research to develop a comprehensive model explaining the predominant risk factors leading to disparities in African American kidney recipients. However, there are still gaps in patient-level data that hinder the deeper understanding of the disparities. Lack of data from the patient often lead to provider biases, which will be addressed with this intervention. Culturally competent, pharmacist-led interventions in medication therapy management will also address therapeutic inertia. Pharmacist interventions will mitigate medication access barriers as well (cost and insurance denials). Thus, this multidimensional intervention addresses patient, provider, and structural factors that drive racial disparities in African American kidney recipients.</p><p><strong>Objective: </strong>This prospective, randomized controlled trial aimed to determine the impact of multimodal health services intervention on health outcomes disparities in African American recipients of kidney transplant. The aims of this study are to improve adherence and control of late clinical issues, which are predominant factors for racial disparities in kidney recipients, through a technology-enabled, telehealth-delivered, 4-level intervention.</p><p><strong>Methods: </strong>The Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) study is a 24-month, 2-arm, single-center (Medical University of South Carolina), 1:1 randomized controlled trial involving 190 participants (95 in each arm), measuring the impact on adherence and control of late clinical issues for racial disparities in kidney recipients, through a technology-enabled, telehealth-delivered, 4-level intervention. The key clinical issues for this study include tacrolimus variability, blood pressure, and glucose control (in those with diabetes mellitus). We will also assess the impact of the intervention on health care use (hospitalizations and emergency department visits) and conduct a cost-benefit analysis. Finally, we will assess the impact of the intervention on acute rejection and graft survival rates as compared with a large contemporary national cohort.</p><p><strong>Results: </strong>This study was funded in July 2023. Enrolled began
背景:非裔美国人肾移植受者的结果差异是一个公共卫生问题,自移植领域成立以来一直困扰着该领域。根据国家数据,与白人受者相比,非裔美国人受者在移植后 5 年的移植物损失风险几乎是白人受者的两倍。有证据表明,不坚持用药和他克莫司的高变异性会严重影响移植结果和种族差异,尤其是在移植后晚期(>2 年)。不坚持用药是造成移植物损失的主要原因。前瞻性多中心数据显示,三分之一的移植物损失直接归因于不依从性。我们花了 10 年时间进行重点研究,建立了一个全面的模型来解释导致非裔美国人肾脏受者差异的主要风险因素。然而,患者层面的数据仍然存在缺口,这阻碍了我们对差异的深入理解。缺乏来自患者的数据往往会导致提供者的偏见,而这项干预措施将解决这一问题。在药物治疗管理方面,由药剂师主导的文化胜任型干预措施也将解决治疗惰性问题。药剂师的干预还将减少药物获取障碍(费用和保险拒绝)。因此,这一多维干预措施可解决导致非裔美国肾脏接受者种族差异的患者、提供者和结构性因素:这项前瞻性随机对照试验旨在确定多模式医疗服务干预对非裔美国人肾移植受者健康结果差异的影响。这项研究的目的是通过技术驱动、远程医疗提供的四级干预措施,改善肾移植受者对后期临床问题的依从性和控制,这些问题是造成种族差异的主要因素:MITIGAAT 是一项为期 24 个月的双臂、单中心(南卡罗来纳医科大学)、1:1 随机对照试验,共有 190 名参与者(每臂 95 人)参加,目的是通过技术辅助、远程医疗、4 级干预,衡量对肾脏受者的依从性和后期临床问题控制的影响,这些问题是造成肾脏受者种族差异的主要因素。这项研究的关键临床问题包括他克莫司的变异性、血压和血糖控制(糖尿病患者)。我们还将评估干预措施对医疗服务使用(住院和急诊就诊)的影响,并进行成本效益分析。最后,我们还将评估干预措施对急性排斥反应和移植物存活率的影响,并将其与当代大型国家队列进行比较:本研究于 2023 年 7 月获得资助。2024 年 4 月开始入组,预计 2026 年完成。所有患者将于 2028 年底完成研究:在本协议中,我们描述了正在进行的 MITIGAAT 临床试验中将使用的研究设计、方法、目的和结果测量:试验注册:ClinicalTrials.gov NCT06023615;https://www.clinicaltrials.gov/study/NCT06023615.International 注册报告标识符(irrid):PRR1-10.2196/57784。
{"title":"Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT Study): Protocol for a Randomized Controlled Trial.","authors":"Morgan Overstreet, Hannah Culpepper, Deanna DeHoff, Mulugeta Gebregziabher, Maria Aurora Posadas Salas, Zemin Su, Jessica Chandler, Felicia Bartlett, Paige Dunton, Taylor Carcella, David Taber","doi":"10.2196/57784","DOIUrl":"10.2196/57784","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The outcome disparities for African American recipients of kidney transplant is a public health issue that has plagued the field of transplant since its inception. Based on national data, African American recipients have nearly twice the risk of graft loss at 5 years after transplant, when compared with White recipients. Evidence demonstrates that medication nonadherence and high tacrolimus variability substantially impact graft outcomes and racial disparities, most notably late (&gt;2 years) after the transplant. Nonadherence is a leading cause of graft loss. Prospective multicenter data demonstrate that one-third of all graft loss are directly attributed to nonadherence. We have spent 10 years of focused research to develop a comprehensive model explaining the predominant risk factors leading to disparities in African American kidney recipients. However, there are still gaps in patient-level data that hinder the deeper understanding of the disparities. Lack of data from the patient often lead to provider biases, which will be addressed with this intervention. Culturally competent, pharmacist-led interventions in medication therapy management will also address therapeutic inertia. Pharmacist interventions will mitigate medication access barriers as well (cost and insurance denials). Thus, this multidimensional intervention addresses patient, provider, and structural factors that drive racial disparities in African American kidney recipients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This prospective, randomized controlled trial aimed to determine the impact of multimodal health services intervention on health outcomes disparities in African American recipients of kidney transplant. The aims of this study are to improve adherence and control of late clinical issues, which are predominant factors for racial disparities in kidney recipients, through a technology-enabled, telehealth-delivered, 4-level intervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) study is a 24-month, 2-arm, single-center (Medical University of South Carolina), 1:1 randomized controlled trial involving 190 participants (95 in each arm), measuring the impact on adherence and control of late clinical issues for racial disparities in kidney recipients, through a technology-enabled, telehealth-delivered, 4-level intervention. The key clinical issues for this study include tacrolimus variability, blood pressure, and glucose control (in those with diabetes mellitus). We will also assess the impact of the intervention on health care use (hospitalizations and emergency department visits) and conduct a cost-benefit analysis. Finally, we will assess the impact of the intervention on acute rejection and graft survival rates as compared with a large contemporary national cohort.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;This study was funded in July 2023. Enrolled began","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e57784"},"PeriodicalIF":1.4,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Cognitive Behavioral Therapy-Based Generative AI Tool (Socrates 2.0) to Facilitate Socratic Dialogue: Protocol for a Mixed Methods Feasibility Study. 基于认知行为疗法的新型生成式人工智能工具(苏格拉底 2.0)促进苏格拉底式对话:混合方法可行性研究协议》。
IF 1.4 Q3 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-10-10 DOI: 10.2196/58195
Philip Held, Sarah A Pridgen, Yaozhong Chen, Zuhaib Akhtar, Darpan Amin, Sean Pohorence
<p><strong>Background: </strong>Digital mental health tools, designed to augment traditional mental health treatments, are becoming increasingly important due to a wide range of barriers to accessing mental health care, including a growing shortage of clinicians. Most existing tools use rule-based algorithms, often leading to interactions that feel unnatural compared with human therapists. Large language models (LLMs) offer a solution for the development of more natural, engaging digital tools. In this paper, we detail the development of Socrates 2.0, which was designed to engage users in Socratic dialogue surrounding unrealistic or unhelpful beliefs, a core technique in cognitive behavioral therapies. The multiagent LLM-based tool features an artificial intelligence (AI) therapist, Socrates, which receives automated feedback from an AI supervisor and an AI rater. The combination of multiple agents appeared to help address common LLM issues such as looping, and it improved the overall dialogue experience. Initial user feedback from individuals with lived experiences of mental health problems as well as cognitive behavioral therapists has been positive. Moreover, tests in approximately 500 scenarios showed that Socrates 2.0 engaged in harmful responses in under 1% of cases, with the AI supervisor promptly correcting the dialogue each time. However, formal feasibility studies with potential end users are needed.</p><p><strong>Objective: </strong>This mixed methods study examines the feasibility of Socrates 2.0.</p><p><strong>Methods: </strong>On the basis of the initial data, we devised a formal feasibility study of Socrates 2.0 to gather qualitative and quantitative data about users' and clinicians' experience of interacting with the tool. Using a mixed method approach, the goal is to gather feasibility and acceptability data from 100 users and 50 clinicians to inform the eventual implementation of generative AI tools, such as Socrates 2.0, in mental health treatment. We designed this study to better understand how users and clinicians interact with the tool, including the frequency, length, and time of interactions, users' satisfaction with the tool overall, quality of each dialogue and individual responses, as well as ways in which the tool should be improved before it is used in efficacy trials. Descriptive and inferential analyses will be performed on data from validated usability measures. Thematic analysis will be performed on the qualitative data.</p><p><strong>Results: </strong>Recruitment will begin in February 2024 and is expected to conclude by February 2025. As of September 25, 2024, overall, 55 participants have been recruited.</p><p><strong>Conclusions: </strong>The development of Socrates 2.0 and the outlined feasibility study are important first steps in applying generative AI to mental health treatment delivery and lay the foundation for formal feasibility studies.</p><p><strong>International registered report identifier (irrid):
背景介绍数字心理健康工具旨在增强传统的心理健康治疗,由于获得心理健康护理的各种障碍,包括临床医生的日益短缺,数字心理健康工具正变得越来越重要。现有的大多数工具都使用基于规则的算法,与人类治疗师相比,往往导致交互感觉不自然。大型语言模型(LLM)为开发更自然、更吸引人的数字工具提供了解决方案。在本文中,我们详细介绍了苏格拉底 2.0 的开发过程,它旨在让用户围绕不现实或无益的信念进行苏格拉底式对话,这是认知行为疗法的核心技术。这款基于多代理 LLM 的工具以人工智能(AI)治疗师苏格拉底(Socrates)为特色,苏格拉底(Socrates)会接收来自 AI 监督员和 AI 评分员的自动反馈。多代理的组合似乎有助于解决常见的 LLM 问题,如循环问题,并改善了整体对话体验。有心理健康问题亲身经历的个人以及认知行为治疗师的初步用户反馈都很积极。此外,在大约 500 个场景中进行的测试表明,苏格拉底 2.0 在不到 1% 的情况下做出了有害的反应,而人工智能主管每次都会及时纠正对话。不过,还需要对潜在的最终用户进行正式的可行性研究:本混合方法研究探讨了苏格拉底 2.0 的可行性:在初步数据的基础上,我们设计了苏格拉底 2.0 的正式可行性研究,以收集有关用户和临床医生与该工具交互体验的定性和定量数据。采用混合方法,我们的目标是从 100 名用户和 50 名临床医生那里收集可行性和可接受性数据,为最终在心理健康治疗中使用苏格拉底 2.0 等生成式人工智能工具提供参考。我们设计这项研究的目的是为了更好地了解用户和临床医生如何与该工具互动,包括互动的频率、长度和时间,用户对工具的总体满意度,每次对话的质量和个人反应,以及该工具在用于疗效试验之前应如何改进。将对经过验证的可用性测量数据进行描述性和推论性分析。将对定性数据进行主题分析:招募工作将于 2024 年 2 月开始,预计于 2025 年 2 月结束。截至 2024 年 9 月 25 日,共招募了 55 名参与者:苏格拉底 2.0 的开发和概述的可行性研究是将生成式人工智能应用于心理健康治疗的重要第一步,并为正式的可行性研究奠定了基础:DERR1-10.2196/58195。
{"title":"A Novel Cognitive Behavioral Therapy-Based Generative AI Tool (Socrates 2.0) to Facilitate Socratic Dialogue: Protocol for a Mixed Methods Feasibility Study.","authors":"Philip Held, Sarah A Pridgen, Yaozhong Chen, Zuhaib Akhtar, Darpan Amin, Sean Pohorence","doi":"10.2196/58195","DOIUrl":"10.2196/58195","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Digital mental health tools, designed to augment traditional mental health treatments, are becoming increasingly important due to a wide range of barriers to accessing mental health care, including a growing shortage of clinicians. Most existing tools use rule-based algorithms, often leading to interactions that feel unnatural compared with human therapists. Large language models (LLMs) offer a solution for the development of more natural, engaging digital tools. In this paper, we detail the development of Socrates 2.0, which was designed to engage users in Socratic dialogue surrounding unrealistic or unhelpful beliefs, a core technique in cognitive behavioral therapies. The multiagent LLM-based tool features an artificial intelligence (AI) therapist, Socrates, which receives automated feedback from an AI supervisor and an AI rater. The combination of multiple agents appeared to help address common LLM issues such as looping, and it improved the overall dialogue experience. Initial user feedback from individuals with lived experiences of mental health problems as well as cognitive behavioral therapists has been positive. Moreover, tests in approximately 500 scenarios showed that Socrates 2.0 engaged in harmful responses in under 1% of cases, with the AI supervisor promptly correcting the dialogue each time. However, formal feasibility studies with potential end users are needed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This mixed methods study examines the feasibility of Socrates 2.0.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;On the basis of the initial data, we devised a formal feasibility study of Socrates 2.0 to gather qualitative and quantitative data about users' and clinicians' experience of interacting with the tool. Using a mixed method approach, the goal is to gather feasibility and acceptability data from 100 users and 50 clinicians to inform the eventual implementation of generative AI tools, such as Socrates 2.0, in mental health treatment. We designed this study to better understand how users and clinicians interact with the tool, including the frequency, length, and time of interactions, users' satisfaction with the tool overall, quality of each dialogue and individual responses, as well as ways in which the tool should be improved before it is used in efficacy trials. Descriptive and inferential analyses will be performed on data from validated usability measures. Thematic analysis will be performed on the qualitative data.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Recruitment will begin in February 2024 and is expected to conclude by February 2025. As of September 25, 2024, overall, 55 participants have been recruited.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The development of Socrates 2.0 and the outlined feasibility study are important first steps in applying generative AI to mental health treatment delivery and lay the foundation for formal feasibility studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;International registered report identifier (irrid): ","PeriodicalId":14755,"journal":{"name":"JMIR Research Protocols","volume":"13 ","pages":"e58195"},"PeriodicalIF":1.4,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11502974/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR Research Protocols
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1